David Happel
Chief Executive Officer at SAGIMET BIOSCIENCES INC.
Net worth: 3 M $ as of 30/04/2024
Profile
David A.
Happel is currently the President, Chief Executive Officer & Director at Sagimet Biosciences, Inc. He previously held the position of Chief Executive Officer at Chrono Therapeutics, Inc. from 2018 to 2020.
From 2020 to 2022, he served as the President & Chief Executive Officer at Cognoa, Inc. Prior to that, he was the Director-Global Marketing at Warner-Lambert Co. in 2000 and the Senior Director-Pulmonary Business Unit at InterMune, Inc. in 2002.
He also worked as the Vice President-Pulmonology at Chiron Corp.
in 2006 and held the position of Head-Sales at Pfizer Inc. He served as the Vice President-Global Sales & Marketing at Dynavax Technologies Corp.
and as the Chief Commercial Officer & EVP at Aerovance, Inc. He was the Executive Vice President-Orphan Business Unit at Horizon Therapeutics Plc from 2016 to 2018 and the Chief Commercial Officer at Horizon Pharmaceutical LLC from 2014 to 2016.
Mr. Happel holds an MBA degree from Indiana State University, which he obtained in 1991, and an undergraduate degree from Indiana University, which he received in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/03/2024 | 639,200 ( 2.10% ) | 3 M $ | 30/04/2024 |
David Happel active positions
| Companies | Position | Start |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Chief Executive Officer | 24/10/2022 |
Former positions of David Happel
| Companies | Position | End |
|---|---|---|
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Chief Executive Officer | 14/11/2022 |
Chrono Therapeutics, Inc.
 Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chrono Therapeutics, Inc. produces transdermal drug products. It is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. The company was founded by Guy DiPierro in 2004 and is headquartered in Hayward, CA. | Chief Executive Officer | 01/03/2020 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/02/2018 |
| RAPTOR PHARMACEUTICAL CORP | Corporate Officer/Principal | 01/10/2016 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2006 |
Training of David Happel
| Indiana University | Undergraduate Degree |
| Indiana State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| SAGIMET BIOSCIENCES INC. | Health Technology |
| Private companies | 10 |
|---|---|
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Distribution Services |
Boomer Esiason Foundation
 Boomer Esiason Foundation Miscellaneous Commercial ServicesCommercial Services Boomer Esiason Foundation is a Non-Profit Organization, which engages in the support of cystic fibrosis community. Its programs includes organ donation, cystic fibrosis scholarship, lung transplant grant, Jerry Cahill cystic fibrosis podcast and Club CF. The company was founded by Cheryl Esiason in 1993 and is headquartered in New York, NY. | Commercial Services |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
| Parke, Davis & Co. LLC | |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Chrono Therapeutics, Inc.
Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chrono Therapeutics, Inc. produces transdermal drug products. It is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. The company was founded by Guy DiPierro in 2004 and is headquartered in Hayward, CA. | Commercial Services |
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Health Services |
- Stock Market
- Insiders
- David Happel
